Shipped in a discreet, unmarked envelope with all required documents enclosed.
Product Sheet
Active Ingredient(s)
Cyproterone Acetate, Ethinylestradiol
Reference Brand
Cyproterone Acetate, Ethinylestradiol
Product Origin
Generic Product
Reference Manufacturer
Bayer
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Women's Health
Product Category
Antiandrogen, Estrogen
Pharmacological Class
Hormonal contraceptive
Clinical Indications
Acne, Hirsutism
Manufacturer Description
This combination is designed to support the management of androgen-dependent skin conditions by balancing hormonal levels.
Mechanism of Action
It inhibits the effects of androgens and suppresses ovulation, which improves skin clarity caused by hormonal imbalance.
Route of Administration
Oral
Onset Time
Days to weeks
Duration
24 hours
Contraindications
History of blood clots, liver disease
Severe Adverse Events
Increased risk of deep vein thrombosis, stroke
Common Side Effects
Nausea, breast tenderness
Uncommon Side Effects
Weight changes, mood swings
Drug Interactions
Rifampicin, Antiepileptics
Pregnancy Safety Warnings
Do not use during pregnancy.
Age Restrictions
Not for pre-pubertal use.
Storage Guidelines
Store below 30°C.
Related Products
Drospirenone and Ethinylestradiol
Information associated with Cyproterone Acetate with Ethinylestradiol is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
